Beth Brooks
Impact in
- Sensory Systems top 2%
- Hearing, Cochlea, Tinnitus, Genetics
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 9
- Lung Cancer Research Studies 5
- Ear and Head Tumors 4
-
- Hearing, Cochlea, Tinnitus, Genetics 7
- Co-authors
- Bruce Carleton (11 shared papers)Colin J.D. Ross (10 shared papers)Shahrad R. Rassekh (9 shared papers)Michael R. Hayden (4 shared papers)Kristin R. Knight (2 shared papers)Marie‐Pierre Dubé (2 shared papers)Henk Visscher (2 shared papers)Andrew Brown (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (2 papers)Therapeutic Drug Monitoring (2 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Beth Brooks
13 papers receiving 565 citations
Peers
Comparison fields: 5 of 71
- Sensory Systems 206
- Pharmacology 76
- Oncology 220
- Otorhinolaryngology 27
- Biophysics 30
Countries citing papers authored by Beth Brooks
This map shows the geographic impact of Beth Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Brooks more than expected).
Fields of papers citing papers by Beth Brooks
This network shows the impact of papers produced by Beth Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Brooks. The network helps show where Beth Brooks may publish in the future.
Co-authors
The 25 scholars most cited alongside Beth Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 231 | |
| 2 | 2013 | 89 | |
| 3 | 2021 | 52 | |
| 4 | 2017 | 44 | |
| 5 | Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. | 2006 | 36 |
| 6 | 2019 | 30 | |
| 7 | 2018 | 28 | |
| 8 | 2021 | 27 | |
| 9 | 2019 | 21 | |
| 10 | 2011 | 15 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2024 | 2 |
About Beth Brooks
Beth Brooks is a scholar working on Oncology, Sensory Systems, Molecular Biology, Plant Science and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 582 indexed citations. Recurring topics across this work include Hearing, Cochlea, Tinnitus, Genetics (7 papers), Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (5 papers), Ear and Head Tumors (4 papers), Plant Molecular Biology Research (3 papers), Brain Metastases and Treatment (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Hemoglobinopathies and Related Disorders (1 paper). The work is most often cited by research in Sensory Systems (206 citations), Pharmacology (76 citations), Oncology (220 citations), Otorhinolaryngology (27 citations) and Biophysics (30 citations). Beth Brooks has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Bruce Carleton, Colin J.D. Ross, Shahrad R. Rassekh, Michael R. Hayden, Kristin R. Knight, Marie‐Pierre Dubé, Henk Visscher, Andrew Brown, Michael Phillips and Paul Rogers. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Therapeutic Drug Monitoring, Cancer, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.